JNJ vs SNDK: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Sandisk Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Sandisk Corporation · Technology
$1,614.39
-25.3% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
JNJ has more upside to fair value
(+5.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
SNDK |
| Current Price |
$270.68 |
$1,614.39 |
| Fair Value Estimate |
$286.05 |
$1,206.72 |
| Upside to Fair Value |
+5.7%
|
-25.3%
|
| Market Cap |
$652.3B |
$239.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
17.9x
|
| Price / Sales |
6.7x
|
11.8x
|
| Price / FCF |
35.3x
|
20.6x
|
| Revenue Growth YoY |
+6.6%
|
+371.6%
|
| Gross Margin |
67.9%
|
71.5%
|
| Operating Margin |
26.8%
|
61.2%
|
| Return on Equity |
25.7%
|
93.1%
|
| Dividend Yield |
1.95% |
0% |
| FCF Yield |
2.83%
|
4.84%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Sandisk designs and manufactures NAND flash storage solutions, including SSDs, embedded memory, removable cards, USB devices, and wafers, employing roughly 11,100 people from its Milpitas, California headquarters. The business is currently generating extraordinary profitability, with TTM gross margin of 71.5%, operating margin of 61.2%, net margin of 56.5%, and ROE of 93.1%, while revenue grew 37…
Accumulation Zones
| Metric |
JNJ |
SNDK |
| Zone Low |
$214.54 |
$905.04 |
| Zone High |
$243.14 |
$1,025.71 |
| In Buy Zone? |
No
|
No
|